发明名称 |
Use of cross-linked amylose as a matrix for the slow release of biologically active compounds |
摘要 |
The present invention is concerned with a solid slow release oral pharmaceutical dosage unit which comprises a solid dosage unit made up of an admixture of a therapeutic dosage of an orally effective pharmaceutical product and a cross-linked polymer of amylose with a cross-linking agent selected from 2,3 dibromopropanol and epichlorohydrin, wherein the cross-linking of the polymer has been carried out with from about 0.1 to about 10 g of cross-linking agent per 100 g of amylose.
|
申请公布号 |
US5456921(A) |
申请公布日期 |
1995.10.10 |
申请号 |
US19940194126 |
申请日期 |
1994.02.09 |
申请人 |
LABOPHARM, INC. |
发明人 |
MATEESCU, MIRCEA A.;LENAERTS, VINCENT;DUMOULIN, YVES |
分类号 |
A61K9/20;A61K9/26;A61K9/36;(IPC1-7):A61K9/26 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|